MNPR
Monopar Therapeutics Inc
85.20$
-4.1%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | +73.4% | +91.0% | +30.6% | +11.1% | +11.8% | +15.6% | -39.9% | +324.1% | |
| – | +0.0% | +0.0% | -96.2% | +91.0% | +18.5% | +22.5% | – | – | – | – | |
| – | -117.7% | – | -256.0% | – | +126.4% | -28.4% | +417.9% | -182.3% | – | -174.5% | |
| – | – | – | – | – | – | -75.0% | -100.0% | – | -100.0% | – | |
| – | – | – | – | – | – | – | – | – | -391.0% | +342.5% | |
| – | – | +272.7% | – | – | -20.9% | -100.0% | +21.2% | -38.7% | -100.0% | – | |
| – | – | – | +0.0% | +0.0% | +0.0% | -100.0% | – | – | – | – | |
| – | -63.3% | +655.4% | -102.2% | – | -12.5% | +33.0% | -99.7% | +6,066.8% | +2,824.8% | +54.4% | |
| – | -97.6% | +10,079.9% | -141.8% | – | -44.3% | +1.2% | -439.7% | – | – | -58.5% | |
| – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.